A new congressional inquiry—not a final finding
WASHINGTON — Republicans on the House Oversight Committee opened an investigation Monday into a Drug Enforcement Administration tactic that allegedly allowed large fentanyl shipments to reach the street while agents tried to build broader criminal cases.
Committee Chairman James Comer of Kentucky sent Attorney General Todd Blanche a letter requesting Justice Department records, according to the Associated Press, which obtained a copy. The request covers policies and decisions tied to the monitoring of fentanyl shipments that agents allegedly did not immediately seize.
The committee's action confirms that Congress is seeking documents. It does not establish that every whistleblower allegation is true, identify who approved any disputed operation or prove that a particular overdose resulted from an unseized shipment.
That line matters. The conduct described is serious enough to demand records and sworn answers, but an investigation is a fact-finding process—not a conviction and not proof by itself.
What whistleblowers allege happened in New Mexico
DEA whistleblowers have alleged that agents in New Mexico were instructed to monitor, rather than intercept, shipments containing hundreds of thousands of fentanyl pills. AP reported that the disputed approach was used between 2023 and 2025 as investigators pursued higher-level traffickers.
The strategy is sometimes described as allowing drugs to 'walk': investigators keep watching a shipment after they know where it is, hoping it leads them to a larger network. Controlled operations can be legitimate investigative tools, but fentanyl creates an unusually severe public-safety risk because a small amount can be lethal.
New Mexico Attorney General Raúl Torrez separately says his office is investigating allegations that the practice occurred from 2022 through 2025. His department sued the Justice Department on August 27 after federal officials did not provide records it requested.
Torrez's lawsuit seeks documents and asks a court to compel or reconsider their release. The state's descriptions of the alleged conduct are claims under investigation; the suit has not produced a judicial finding that federal agents violated the law.
Justice Department watchdog is already reviewing the policy
The Justice Department inspector general announced a separate review on August 17. That official review is examining how department personnel assess and mitigate danger when they know or have probable cause to believe fentanyl will be transported, distributed or stored at an identifiable location.
The inspector general says the review will look at when interdiction is delayed or declined, who makes and approves those decisions, how disagreements are handled and whether decisions are documented or reviewed afterward. Its primary focus is the last two years, with earlier New Mexico cases included when needed for context.
The watchdog has not announced conclusions. DEA Administrator Terry Cole told Fox News that the agency's investigations are complex and conducted under the law, and he welcomed the inspector general's review, AP reported.
That response is not a detailed accounting of the disputed operations. It is the agency leadership's position while the inspector general, New Mexico authorities and now Congress pursue records.
The fight now centers on policy changes and accountability
Comer is asking about a 2024 revision to Justice Department fentanyl-risk protocols. AP reported that a 2017 policy told agents to seize or otherwise prevent distribution as soon as practicable, while the later language gave investigators more discretion to preserve an investigation.
Comer's request focuses on the Biden administration and accuses it of weakening protections. AP also reported, however, that the disputed investigative approach continued into President Donald Trump's second administration before a May 2025 operation described as the largest fentanyl bust in DEA history.
The dates complicate any simple partisan explanation. The central questions are operational: who knew the shipments were moving, what risks were documented, what alternatives were considered, who approved the decisions and whether agents lost control of fentanyl that reached communities.
Those answers should come from records, testimony and completed investigations—not campaign slogans or unsupported assumptions about individual cases.
What is confirmed and what remains unresolved
Confirmed: the House Oversight chairman requested Justice Department records Monday; the Justice Department inspector general is conducting an official review; New Mexico's attorney general sued for related records last week; and DEA whistleblowers have made allegations about monitored fentanyl shipments.
Not yet established: the full number of shipments, pills or resulting deaths; the identities of every official who authorized the disputed tactics; whether each operation violated policy or law; and whether Congress, the inspector general or a court will find wrongdoing.
The public deserves a complete accounting because the allegation is not about a paperwork mistake. It is about whether a law-enforcement strategy exposed communities to preventable danger. The demand now is evidence: release the records, preserve the chain of command and separate confirmed decisions from accusations.
Sources and further reading
Associated Press: House Oversight Committee opens inquiry into DEA fentanyl tactic ↗
Justice Department inspector general: Review of fentanyl-investigation risk mitigation ↗
New Mexico Department of Justice: Lawsuit seeking records on DEA handling of fentanyl ↗
DEA: Official fentanyl image gallery ↗
Related Kern County coverage: Free Narcan and Bakersfield's 152-flag overdose memorial ↗